← Leaderboards
Ningling Kang
Mayo Clinic Rochester
$5,654,068
Attributed
$5,823,257
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $695.5K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,823,257 · 3
By mechanism
R01$5,142,221 · 2
K01$681,036 · 1
Top collaborators
- Eunmiri Roh1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Robert Christian Huebert$3,407,136
- Adebowale O Bamidele$965,201
Others in their field
Top investigators on “Tumor”
- David Heimbrook · Leidos Biomedical Research, Inc.$636,492,067
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Gregory H Reaman · National Childhood Cancer Foundation$208,276,509
- Richard K. Wilson · Washington University$203,917,615
- Norman Wolmark · Nsabp Foundation, Inc.$177,323,696
- Ronald T Mitsuyasu · University Of California Los Angeles$138,361,819
Research focus
TumorIn VivoSignal TransductionIn VitroHepatic Stellate CellLiverRegulationMetastatic Neoplasm To The LiverLiver NeoplasmsNeoplasm MetastasisMediatingImplantationTumor GrowthGrowthMalignant NeoplasmsNeoplastic CellMyofibroblastKnockout MiceTransforming Growth Factor BetaCellular BiologyPhosphorylationComplexSignal PathwayProteins
Grant awards (21)
Hepatic Stellate Cell Regulation of Metastatic Growth in the Liver$377,625
R01 · FY2025 · CA · contact PI
Hepatic Stellate Cell Regulation of Metastatic Growth in the Liver$358,744
R01 · FY2024 · CA · contact PI
Hepatic Stellate Cell Regulation of Metastatic Growth in the Liver$377,625
R01 · FY2023 · CA · contact PI
Hepatic Stellate Cell Regulation of Metastatic Growth in the Liver$377,625
R01 · FY2022 · CA · contact PI
Hepatic stellate cell regulation of metastatic growth in the liver$368,125
R01 · FY2021 · CA · contact PI
Hepatic stellate cell regulation of metastatic growth in the liver$368,125
R01 · FY2020 · CA · contact PI
Hepatic stellate cell regulation of metastatic growth in the liver$357,081
R01 · FY2019 · CA · contact PI
Chemoprevention of colon cancer by targeting the Wnt/beta-catenin pathway$338,378
R01 · FY2019 · CA · contact PI
Hepatic stellate cell regulation of metastatic growth in the liver$368,125
R01 · FY2018 · CA · contact PI
Hepatic stellate cell regulation of metastatic growth in the liver$368,125
R01 · FY2017 · CA · contact PI
HEPATIC STELLATE CELL REGULATION OF METASTATIC GROWTH IN THE LIVER$315,266
R01 · FY2015 · CA · contact PI
HEPATIC STELLATE CELL REGULATION OF METASTATIC GROWTH IN THE LIVER$298,608
R01 · FY2014 · CA · contact PI
HEPATIC STELLATE CELL REGULATION OF METASTATIC GROWTH IN THE LIVER$207,245
R01 · FY2013 · CA · contact PI
HEPATIC STELLATE CELL REGULATION OF METASTATIC GROWTH IN THE LIVER$7,068
R01 · FY2013 · CA · contact PI
HEPATIC STELLATE CELL REGULATION OF METASTATIC GROWTH IN THE LIVER$327,228
R01 · FY2012 · CA · contact PI
HEPATIC STELLATE CELL REGULATION OF METASTATIC GROWTH IN THE LIVER$327,228
R01 · FY2011 · CA · contact PI
Mechanism of nitric oxide inhibition of pericyte recruitment in liver tumors$129,408
K01 · FY2011 · CA · contact PI
Mechanism of nitric oxide inhibition of pericyte recruitment in liver tumors$158,588
K01 · FY2010 · CA · contact PI
Mechanism of nitric oxide inhibition of pericyte recruitment in liver tumors$133,942
K01 · FY2009 · CA · contact PI
Mechanism of nitric oxide inhibition of pericyte recruitment in liver tumors$130,985
K01 · FY2008 · CA · contact PI
Mechanism of nitric oxide inhibition of pericyte recruitment in liver tumors$128,113
K01 · FY2007 · CA · contact PI